Braiin Ltd (BRAI) Chief Strategy Officer reports zero Ordinary Share ownership
Braiin Ltd's Chief Strategy Officer, Pandey Samir, filed an amended insider ownership report (Form 3/A) indicating zero direct ownership of Ordinary Shares as of March 18, 2026. This filing clarifies his baseline ownership status rather than reporting a transaction. The report does not show any derivative securities for Pandey Samir.
Pfizer, Zai Lab win China nod for cervical cancer therapy Tivdak
Chinese biotech Zai Lab Limited, in collaboration with Pfizer and Genmab, has received approval from Chinese regulators for its antibody-drug conjugate Tivdak. This approval is for Tivdak as a late-line treatment for adult patients with cervical cancer. The National Medical Products Administration in China has cleared the drug for this indication.
J.M. Smucker Expects Sales to Fall This Year
J.M. Smucker expects its net sales to decline by 3% to 4% in its fiscal 2027, shifting focus from price increases to volume growth and profitability. The company also projected adjusted earnings per share between $9.75 and $10.25, aligning with or slightly above analyst expectations. This forecast contrasts with FactSet analysts' prediction of a 0.4% sales increase for the company, known for brands like Jif peanut butter and Folgers coffee.
Does Intuitive Surgical’s (ISRG) Ion-Focused Promotion Reveal Its Next Strategic Growth Priority?
Intuitive Surgical has promoted Taylor Patton, global Senior Vice President of its endoluminal business, to Chief Commercial and Marketing Officer, effective July 1. This move elevates an executive who oversaw the launch of the Ion platform, signaling Intuitive's increased focus on scaling its multi-platform, procedure-centric business. While this leadership change reinforces the company's strategy, it's considered incremental, with the core investment narrative still hinging on robotic-assisted procedure growth and effective management of recent FDA Class I recalls.
Applied Materials Announces Cash Dividend
Applied Materials, Inc. announced that its Board of Directors has approved a quarterly cash dividend of $0.53 per share, payable on September 10, 2026, to shareholders of record as of August 20, 2026. This dividend, increased by 15% in March 2026, marks nine consecutive years of dividend increases and is a key part of the company's capital allocation strategy. Over the last decade, Applied Materials has grown its dividend per share at an 18% compound annual growth rate and distributed nearly 90% of free cash flow to shareholders through dividends and share repurchases.
Applied Materials dividend per share up 18% a year over the last decade
Applied Materials (NASDAQ: AMAT) has declared a quarterly cash dividend of $0.53 per share, payable on September 10, 2026, to shareholders recorded by August 20, 2026. This announcement highlights nine consecutive years of dividend increases, a 10-year dividend CAGR of 18%, and a significant return of capital to shareholders through dividends and share repurchases, totaling nearly 90% of free cash flow over the past decade. The company also disclosed $765 million distributed in Q2 FY2026 and $13.2 billion remaining in its share repurchase authorization.
Truist names former BofA executive Cathy Bessant to board of directors
Truist Financial has appointed Cathy Bessant, a veteran executive with 40 years of experience at Bank of America, to its board of directors. Bessant is recognized as one of the most distinguished executives in U.S. banking. This move brings her extensive expertise to the Charlotte-based financial institution.
PNC DCF Analysis: Intrinsic Value $247 vs Price $227
A Discounted Cash Flow (DCF) analysis for PNC Financial Services Group Inc (PNC) reveals an earnings-based intrinsic value of $247.27, suggesting the stock is fair valued with an 8.1% margin of safety compared to its current price of $227.14. However, the Free Cash Flow (FCF) based DCF model provides a slightly lower intrinsic value of $223.58, indicating a -1.6% margin of safety, while the GF Value™ suggests the stock is 12.5% overvalued at $201.95. Investors are advised to consider these varying perspectives, especially given PNC's low predictability rank of 2 out of 5 stars, which may affect the reliability of the DCF model.
Costco Stock at $975: Here’s the $1,400 Case
Costco (COST) stock recently dropped despite beating Q3 2026 earnings expectations, primarily due to market misinterpretation of gross margin dilution caused by record fuel volumes, which are a loyalty acquisition tool for Costco. Analysts have raised price targets, and the TIKR model projects a base case valuation of $1,407 by August 2030, suggesting significant undervaluation relative to its forward earnings trajectory. The article argues that Costco's membership-driven model and strong EPS growth, outperforming competitors like Walmart and BJ's Wholesale, supports a buy thesis for the stock.
J. M. Smucker Releases Q4 2026 Financial Results
The J. M. Smucker Company reported strong Q4 2026 financial results, with adjusted earnings per share of $2.77, significantly exceeding analyst estimates. Revenue increased by 6.0% to $2.27 billion, driven by strong performance in U.S. Retail Coffee. The company also provided an optimistic FY 2027 adjusted EPS projection, though analyst sentiment remains mixed.




